TNF-Bound Colloidal Gold in Treating Patients With Advanced Solid Tumors
This study has been completed.
Information provided by:
National Institutes of Health Clinical Center (CC)
First received: July 26, 2006
Last updated: March 14, 2012
Last verified: March 2012
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||April 2009|
|Primary Completion Date:||February 2009 (Final data collection date for primary outcome measure)|
Libutti SK, Paciotti GF, Byrnes AA, Alexander HR Jr, Gannon WE, Walker M, Seidel GD, Yuldasheva N, Tamarkin L. Phase I and pharmacokinetic studies of CYT-6091, a novel PEGylated colloidal gold-rhTNF nanomedicine. Clin Cancer Res. 2010 Dec 15;16(24):6139-49. doi: 10.1158/1078-0432.CCR-10-0978. Epub 2010 Sep 27.